Medicinal chemistry, Lead optimization, In vitro drug screening
  Home
  The Latitude Team
  Expertise and Specialties
  Formulation Services
  Preformulation Services
  Analytical Methods
Development
  Platform Technologies
  R&D and Pilot Scale Manufacturing
  cGMP Manufacturing
  Employment Opportunities
  News/Press Releases
  Case Studies
  Contact Us
img

News/Press Releases on Latitude and its Formulations

Sept. 15, 2009  Nano-E Antibacterial Emulsion Poster 49th ICAAC Annual Meeting
July 16, 2009 Latitude Signs Two More Collaboration Studies for PG Depot.
May  12, 2009 Nanoemulsions are a Superior Approach to Formulating Insoluble IV Drugs.
May  07, 2009 ADVENTRX Announces Results form ANX-514 Bioequivalence Trial.
July 02, 2008 PainReform Licenses A Novel Sustained Release Formulation of Ropivacaine from Encore Therapeutics, Inc.
May 16, 2008 ADVENTRX Announces ANX-530 Safety Data From Registrational Bioequivalence Clinical Study.
May  10, 2008 Novalar Receives FDA Approval For OraVerse.
img
img
Latitude Pharmaceuticals Inc
Copyright 2003 - 2009 All rights reserved